Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Alzheimers Res Ther ; 16(1): 109, 2024 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-38750512

RESUMEN

BACKGROUND: As one major symptom of Alzheimer's disease (AD), anterograde amnesia describes patients with an inability in new memory formation. The crucial role of the entorhinal cortex in forming new memories has been well established, and the neuropeptide cholecystokinin (CCK) is reported to be released from the entorhinal cortex to enable neocortical associated memory and long-term potentiation. Though several studies reveal that the entorhinal cortex and CCK are related to AD, it is less well studied. It is unclear whether CCK is a good biomarker or further a great drug candidate for AD. METHODS: mRNA expressions of CCK and CCK-B receptor (CCKBR) were examined in two mouse models, 3xTg AD and CCK knock-out (CCK-/-) mice. Animals' cognition was investigated with Morris water maze, novel object recognition test and neuroplasticity with in-vitro electrophysiological recording. Drugs were given intraperitoneally to animals to investigate the rescue effects on cognitive deficits, or applied to brain slices directly to explore the influence in inducement of long-term potentiation. RESULTS: Aged 3xTg AD mice exhibited reduced CCK mRNA expression in the entorhinal cortex but reduced CCKBR expression in the neocortex and hippocampus, and impaired cognition and neuroplasticity comparable with CCK-/- mice. Importantly, the animals displayed improved performance and enhanced long-term potentiation after the treatment of CCKBR agonists. CONCLUSIONS: Here we provide more evidence to support the role of CCK in learning and memory and its potential to treat AD. We elaborated on the rescue effect of a promising novel drug, HT-267, on aged 3xTg AD mice. Although the physiological etiology of CCK in AD still needs to be further investigated, this study sheds light on a potential pharmaceutical candidate for AD and dementia.


Asunto(s)
Enfermedad de Alzheimer , Amnesia Anterógrada , Colecistoquinina , Ratones Transgénicos , Receptor de Colecistoquinina B , Animales , Ratones , Envejecimiento/efectos de los fármacos , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Amnesia Anterógrada/tratamiento farmacológico , Colecistoquinina/metabolismo , Modelos Animales de Enfermedad , Corteza Entorrinal/efectos de los fármacos , Corteza Entorrinal/metabolismo , Hipocampo/metabolismo , Hipocampo/efectos de los fármacos , Potenciación a Largo Plazo/efectos de los fármacos , Ratones Endogámicos C57BL , Ratones Noqueados , Receptor de Colecistoquinina B/genética , Receptor de Colecistoquinina B/agonistas , Receptor de Colecistoquinina B/deficiencia
2.
PeerJ Comput Sci ; 10: e1870, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38435581

RESUMEN

It is critical to accurately predict the future popularity of information cascades for many related applications, such as online opinion warning or academic influence evaluation. Despite many efforts devoted to developing effective prediction approaches, especially the recent presence of deep learning-based model, the structural information of the cascade network is ignored. Thus, to make use of the structural information in cascade prediction task, we propose a structural-topic aware deep neural networks (STDNN), which firstly learns the structure topic distribution of each node in the cascade, feeds it to a sequential neural network, and finally predicts the future popularity of the cascades. It can inherit the high interpretability of Hawkes process and possesses the high predictive power of deep learning methods, bridging the gap between prediction and understanding of information cascades by capturing indicative graph structures. We evaluate our model through quantitative experiments, where our model exhibits promising performance, efficiency higher than the baselines.

3.
Elife ; 132024 Mar 04.
Artículo en Inglés | MEDLINE | ID: mdl-38436304

RESUMEN

The entorhinal cortex is involved in establishing enduring visuo-auditory associative memory in the neocortex. Here we explored the mechanisms underlying this synaptic plasticity related to projections from the visual and entorhinal cortices to the auditory cortex in mice using optogenetics of dual pathways. High-frequency laser stimulation (HFS laser) of the visuo-auditory projection did not induce long-term potentiation. However, after pairing with sound stimulus, the visuo-auditory inputs were potentiated following either infusion of cholecystokinin (CCK) or HFS laser of the entorhino-auditory CCK-expressing projection. Combining retrograde tracing and RNAscope in situ hybridization, we show that Cck expression is higher in entorhinal cortex neurons projecting to the auditory cortex than in those originating from the visual cortex. In the presence of CCK, potentiation in the neocortex occurred when the presynaptic input arrived 200 ms before postsynaptic firing, even after just five trials of pairing. Behaviorally, inactivation of the CCK+ projection from the entorhinal cortex to the auditory cortex blocked the formation of visuo-auditory associative memory. Our results indicate that neocortical visuo-auditory association is formed through heterosynaptic plasticity, which depends on release of CCK in the neocortex mostly from entorhinal afferents.


Asunto(s)
Colecistoquinina , Corteza Entorrinal , Ratones , Animales , Corteza Entorrinal/fisiología , Colecistoquinina/metabolismo , Potenciación a Largo Plazo/fisiología , Plasticidad Neuronal/fisiología , Neuronas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA